5-methylurapidil has been researched along with Adenoma, Prostatic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kenny, B | 1 |
Ballard, S | 1 |
Blagg, J | 1 |
Fox, D | 1 |
Elworthy, TR | 1 |
Ford, AP | 1 |
Bantle, GW | 1 |
Morgans, DJ | 1 |
Ozer, RS | 1 |
Palmer, WS | 1 |
Repke, DB | 1 |
Romero, M | 1 |
Sandoval, L | 1 |
Sjogren, EB | 1 |
Talamás, FX | 1 |
Vazquez, A | 1 |
Wu, H | 1 |
Arredondo, NF | 1 |
Blue, DR | 1 |
DeSousa, A | 1 |
Gross, LM | 1 |
Kava, MS | 1 |
Lesnick, JD | 1 |
Vimont, RL | 1 |
Williams, TJ | 1 |
Zhu, QM | 1 |
Pfister, JR | 1 |
Clarke, DE | 1 |
1 review available for 5-methylurapidil and Adenoma, Prostatic
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlle | 1997 |
1 other study available for 5-methylurapidil and Adenoma, Prostatic
Article | Year |
---|---|
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amid | 1997 |